About TrePsy

Twinning TrePsy – “Towards new treatments of psychiatric
disorders – a systems-oriented approach”

Promotional Videos:

Our Mission

The mission of the project is to create a unique advanced research curriculum for students and early-career scientists, who will lead future neuropharmacological research, and form a cluster of institutions of excellence in the fields of Neuropsychopharmacology.

The project will provide students, and PhD programme participants with lectures and training in emerging topics and research methodologies.
We focus on brain research – study of neuronal and molecular mechanisms involved in the actions of cannabidiol.

Project duration: 1st November 2022 – 31st October 2025

Partners

4 European partners – leading European brain research centres in development of novel treatments of psychiatric disorders:

Maj Institute of Pharmacology of the Polish Academy of Sciences
Krakow, Poland

Miguel Hernández University
Alicante, Spain

Central Institute of Mental Health Mannheim, Germany

Neurocentre Magendie
Bordeaux, France

Find out more

Latest News

See the latest news from our Facebook page

Go to our Facebook

🎬 TrePsy – European consortium delivers new systems-oriented insights in neuropsychopharmacologyThe project – Towards new treatments of psychiatric disorders: a systems-oriented approach has successfully completed its three-year research and training mission.Funded by the European Union’s Horizon Europe programme as a Widening Twinning initiative, TrePsy brought together the expertise of the Maj Institute of Pharmacology, Polish Academy of Sciences and leading European research institutions:🇫🇷 Neurocentre Magendie INSERM🇩🇪 Zentralinstitut für Seelische Gesundheit🇪🇸 UMH Universidad Miguel Hernándezez🧠 The project focused on advancing a systems-oriented approach to neuropsychopharmacology and decoding the complex mechanisms of Cannabidiol / CBD.TrePsy combined cutting-edge research methods with advanced training activities, including:🔬 state-of-the-art multiomics technologies,🧩 advanced in vivo imaging,🧠 high-resolution brain maps,📚 multiple peer-reviewed publications,🎓 training opportunities for early-career researchers and young scientists.Beyond the laboratory, TrePsy made a strong contribution to scientific capacity-building by hosting six advanced scientific schools and launching a University Specialist programme focused on cannabinoid derivatives.As highlighted by Jan Rodriguez Parkitna from the project coordination team:“This collaboration has not only raised the research excellence of IP PAS but has also fostered a robust network of early-career scientists equipped with the latest systems-biology tools.”📌 The results of TrePsy provide an important scientific foundation for further research and informed policy-making on the therapeutic use of cannabinoids.🎥 A final project movie summarising these milestones is now available online.👉 Watch the materials and follow the project results:▶️ TrePsy YouTube channel: www.youtube.com/@TwinningTrePsy▶️ IF PAN YouTube channel: youtube.com/@ifpan-yk1nh?si=ndZpqAMZyvs4XIpl🌐 Project website: twinning-trepsy.eu/#TrePsy #HorizonEurope #Twinning #Neuropsychopharmacology #CBD #Cannabidiol #SystemsBiology #Multiomics #InVivoImaging #IFPAN #ScienceCommunication #ResearchImpact #EuropeanResearchArea #WideningParticipation ... See MoreSee Less

View on Facebook

🎥❄️ Although several months have passed since the 2026 Winter School, today we are revisiting this special event with the release of a report summarizing the final TrePsy School.The film is also an opportunity to reflect on three years of collaboration within the TrePsy consortium, a Horizon Europe Twinning project bringing together leading researchers and institutions from across Europe. In the video, participants, lecturers, and project partners share their perspectives on the project's key achievements and the future of research in neuropsychopharmacology.Over the course of the TrePsy project, we:🔹 organized six international scientific schools,🔹 advanced a systems-oriented approach to studying the mechanisms of Cannabidiol (CBD),🔹 applied cutting-edge multiomics technologies and advanced in vivo imaging methods,🔹 launched a University Specialist programme focused on cannabinoid derivatives,🔹 made more than 20 online lectures available to the scientific and educational community,🔹 strengthened collaboration between the Instytut Farmakologii im. Jerzego Maja Polskiej Akademii Nauk and partner institutions in France, Germany, and Spain.One of the themes that emerged during the project's final activities was the growing role of Artificial Intelligence in neuropsychopharmacology and its potential to shape the future of biomedical research.🎬 youtu.be/-kRZjzbheX0We invite you to watch the report and join us in looking back on this remarkable scientific journey.Zentralinstitut für Seelische Gesundheit UMH Universidad Miguel Hernández Neurocentre Magendie ... See MoreSee Less

View on Facebook